Scarica l'app Stockscreener
5.65
0.00%
0.00
Dopo l'orario di chiusura:
5.67
0.02
+0.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.65
Aprire:
$5.73
Volume 24 ore:
2.19M
Relative Volume:
1.91
Capitalizzazione di mercato:
$322.02M
Reddito:
$5.82M
Utile/perdita netta:
$71.18M
Rapporto P/E:
5.6659
EPS:
0.9972
Flusso di cassa netto:
$-84.30M
1 W Prestazione:
+5.41%
1M Prestazione:
+2.91%
6M Prestazione:
+16.49%
1 anno Prestazione:
-5.83%
Intervallo 1D:
$5.56
$5.775
Intervallo di 1 settimana:
$5.295
$5.80
Portata 52W:
$4.00
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Nome
Abeona Therapeutics Inc
Settore
Industria
Telefono
646-813-4701
Indirizzo
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.65 | 323.16M | 5.82M | 71.18M | -84.30M | 0.9972 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-03-05 | Iniziato | Oppenheimer | Outperform |
| 2024-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-30 | Iniziato | Stifel | Buy |
| 2020-11-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-02-10 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Ripresa | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Downgrade | Maxim Group | Buy → Hold |
| 2019-08-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Downgrade | Mizuho | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2018-10-12 | Iniziato | Mizuho | Buy |
| 2018-06-05 | Iniziato | Seaport Global Securities | Buy |
| 2017-11-08 | Iniziato | SunTrust | Buy |
| 2017-10-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Iniziato | Citigroup | Buy |
| 2017-10-05 | Reiterato | Maxim Group | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-18 | Reiterato | Maxim Group | Buy |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2017-01-06 | Iniziato | Jefferies | Buy |
| 2016-09-29 | Reiterato | Maxim Group | Buy |
Mostra tutto
Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie
Abeona Therapeutics director Christine Silverstein sells $103,695 in stock By Investing.com - Investing.com Australia
Abeona Therapeutics (ABEO) director sells 18,160 shares to cover tax - Stock Titan
[144] ABEONA THERAPEUTICS INC. SEC Filing - Stock Titan
Abeona Therapeutics Inc. (ABEO) 8-K Filing June 12, 2026: Submission of Matters to a Vote of Security Holders - Minichart
Abeona Therapeutics (ABEO) investors approve equity plan boost, keep director notice rule - Stock Titan
ABEO: All proposals passed except the advance notice provision amendment for director nominations - TradingView
Abeona Therapeutics Inc. Announces Resignation of Michael Amoroso as Member of Board of Directors, Nominating and Corporate Governance Committee, Effective June 11, 2026 - marketscreener.com
Michael Amoroso resigns from Abeona board and nominating committee - TradingView
Abeona (NASDAQ: ABEO) director Michael Amoroso steps down from board - Stock Titan
Updated Abeona Therapeutics (NASDAQ: ABEO) investor presentation furnished in 8-K filing - Stock Titan
Abeona Therapeutics CFO Joseph Vazzano sells $265,242 in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CCO Vasanthavada Madhav sells $51,548 in shares. - Investing.com UK
Abeona Therapeutics CEO sells $301,920 in stock By Investing.com - Investing.com South Africa
Abeona Therapeutics CCO Vasanthavada Madhav sells $51,548 in shares. By Investing.com - Investing.com Nigeria
Abeona Therapeutics SVP, chief legal officer sells $59,645 in stock - Investing.com UK
Abeona Therapeutics CEO sells $301,920 in stock - Investing.com India
Abeona Therapeutics SVP, chief legal officer sells $59,645 in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CFO Joseph Vazzano sells $265,242 in stock - Investing.com
[Form 4] ABEONA THERAPEUTICS INC. Insider Trading Activity - Stock Titan
Abeona Therapeutics (ABEO) CFO sells 49,338 shares under 10b5-1 tax plan - Stock Titan
(ABEO) Volatility Zones as Tactical Triggers - Stock Traders Daily
ABEO (NASDAQ: ABEO) insider sales: 13,421 shares reported, plus 785-share sale - Stock Titan
ABEO (NASDAQ: ABEO) notice: proposed resale of 10,000 shares via Stifel - Stock Titan
ABEO (NASDAQ: ABEO) files Form 144 to sell 112,276 compensation shares - Stock Titan
Proposed resale notice — ABEO (Nasdaq: ABEO) lists 25,000 shares - Stock Titan
Abeona Advances ABO-701 T-Cell Therapy Toward IND - The Globe and Mail
Abeona Therapeutics reports constructive Pre-IND meeting with FDA on ABO-701, IND targeted for 2027 - TradingView
Abeona Therapeutics (ABEO) details FDA Pre-IND meeting and 2027 IND goal for ABO-701 - Stock Titan
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Price-Driven Insight from (ABEO) for Rule-Based Strategy - Stock Traders Daily
ABEO Reiterated by HC Wainwright & Co. -- Price Target Maintained at $20 - GuruFocus
H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Abeona Therapeutics (ABEO) director reports bona fide 500-share gift - Stock Titan
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - The Manila Times
Abeona plans Jefferies fireside chat, Goldman investor meetings - Stock Titan
ABEOAbeona Therapeutics Inc Stock Price and Quote - Finviz
Lightning eMotors Inc. (ZEV) - Minichart
Abeona Therapeutics director Mark Alvino sells $35,462 in stock By Investing.com - Investing.com India
Insider Sell: Mark Alvino Sells 6,500 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus
Abeona Therapeutics director Mark Alvino sells $35,462 in stock - Investing.com UK
Abeona Therapeutics (ABEO) director sells 6,500 shares in open-market trade - Stock Titan
May 2026's Top Insider-Owned Growth Companies - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
Abeona Therapeutics (NASDAQ: ABEO) Reports $8.7 Million in Q1 Revenue as ZEVASKYN Adoption Accelerates - foreignpolicyjournal.com
Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum - TipRanks
Daily Brief Health Care: Dermavon Holdings, Alebund Pharmaceuticals Jiangsu, Alnylam Pharmaceuticals, Artrya , Bavarian Nordic A/S, Cardinal Health, Dexcom Inc, American Shared Hospital Servi, Eli Lilly & Co, Abeona Therapeutics and more - Smartkarma
(ABEO) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ABEO: Three Patients Treated in 1Q26 with Two Additional QTCs Activated - Zacks Small Cap Research
Earnings call transcript: Abeona Therapeutics beats Q1 2026 forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Abeona Therapeutics beats Q1 2026 forecasts, stock dips - Investing.com
Abeona Therapeutics Inc Azioni (ABEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.60%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):